glp-1 trends Receptor Agonist Market Size GLP-1 Analogues Market Report, Growth
Description
It typically results from inadequate insulin secretion because of dysfunction of the insulin-secreting pancreatic beta cells
The future development and availability of biosimilars or generic formulations will be crucial for improving affordability and equitable access
In recent years, glucagon-like peptide-1 receptor agonists (GLP-1RAs) have emerged as cornerstone therapies in the management of T2D and obesity [5,6,7]
These medications, when used correctly with proper medical supervision and lifestyle modifications, can be genuinely life-changing
